Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 9, Issue 6, 2008, Pages 339-349

  Palma, Angelina S ^a   De Carvalho, Mamede ^b,c   Grammel, Nicolas ^d   Pinto, Susana ^b,c   Barata, Nuno ^a   Conradt, Harald S ^d   Costa, Julia ^a,e  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d GlycoThera GmbH   (Germany)

^e INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

Author keywords

Amyotrophic lateral sclerosis; Biomarkers; Mass spectrometry; Plasma; Two dimensional electrophoresis

Indexed keywords

BIOLOGICAL MARKER; RILUZOLE; VITAMIN D BINDING PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; IMMUNODETECTION; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PORTUGAL; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN TARGETING; PROTEOMICS; RISK FACTOR; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PORTUGAL; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VITAMIN D-BINDING PROTEIN;

EID: 54049158488     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960801934239     Document Type: Article

References (38)

1. Bruijn, LI, Miller, TM and Cleveland, DW. (2004) Unravelling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci., 27, pp. 723-749.
2. Rosen, DR, Siddique, T., Patterson, D., Figlewicz, DA, Sapp, P. Hentati, A. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature., 362, pp. 59-62.
3. Brooks, BR, Miller, RG, Swash, M. and Munsat, TL. (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord., 1, pp. 293-299.
4. de Carvalho, M. and Swash, M. (2006) Conventional neurophysiology in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, pp. 105-123. Informa UK Ltd
5. Nirmalananthan, N. and Greensmith, L. (2005) Amyotrophic lateral sclerosis: Recent advances and future therapies. Curr Opin Neurol., 18, pp. 712-719.
6. Sheta, EA, Appel, SH and Goldknopf, IL. (2006) 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases. Expert Rev Proteomics., 3, pp. 45-62.
7. Bowser, R., Cudkowicz, M. and Kaddurah-Daouk, R. (2006) Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn., 6, pp. 387-398.
8. Sanchez, J. and Hochstrasser, D. (1999) Preparation and solubilization of body fluids for 2-D. 2-D Proteome Analysis Protocols (Methods in Molecular Biology), pp. 87-103. Humana Press Inc, Totowa
9. Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, GM Carnemolla, B. et al. (2004) 2 Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis., 25, pp. 1327-1333.
10. Wang, W., Sun, J., Nimtz, M., Deckwer, WD and Zeng, AP. (2003) Protein identification from two-dimensional gel electrophoresis analysis of Klebsiella pneumoniae by combined use of mass spectrometry data and raw genome sequences. Proteome Sci., 1, p. 6.
11. Palma, A., de Carvalho, M., Barata, N., Evangelista, T., Chicau, P. Regalla, M. et al. (2005) Biochemical characterization of plasma in amyotrophic lateral sclerosis: Amino acid and protein composition. Amyotroph Lateral Scler Other Motor Neuron Disord., 6, pp. 104-110.
12. Sanchez, JC, Appel, RD, Golaz, O., Pasquali, C., Ravier, F. Bairoch, A. et al. (1995) Inside SWISS-2DPAGE database. Electrophoresis., 16, pp. 1131-1151.
13. Speeckaert, M., Huang, G., Delanghe, JR and Taes, YE. (2006) Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta., 372, pp. 33-42.
14. White, P. and Cooke, N. (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab., 11, pp. 320-327.
15. Kofler, A., Braun, A., Jenkins, T., Serjeantson, SW and Cleve, H. (1995) Characterization of mutants of the vitamin-D-binding protein/group specific component: GC aborigine (1A1) from Australian aborigines and South African blacks, and 2A9 from south Germany. Vox Sang., 68, pp. 50-54.
16. Nagasawa, H., Uto, Y., Sasaki, H., Okamura, N., Murakami, A. Kubo, S. et al. (2005) Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res., 25, pp. 3689-3695.
17. de Carvalho, M. and Swash, M. (2006) Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?. Arch Neurol., 63, pp. 557-560.
18. Ramstrom, M., Ivonin, I., Johansson, A., Askmark, H., Markides, KE Zubarev, R. et al. (2004) Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics., 4, pp. 4010-4018.
19. Ranganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V., Lacomis, D. Urbinelli, L. et al. (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem., 95, pp. 1461-1471.
20. Pasinetti, GM, Unger, LH, Lange, DJ, Yemul, S., Deng, H., Yuan, X. Brown, RH et al. (2006) Identification of potential CSF biomarkers in ALS. Neurology., 66, pp. 1218-1222.
21. Beuche, W., Yushchenko, M., Mader, M., Maliszewska, M., Felgenhauer, K. and Weber, F. (2000) Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport., 11, pp. 3419-3422.
22. Neumann, M., Kwong, LK, Sampathu, DM, Trojanowski, JQ and Lee, VM. (2007) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: Protein misfolding diseases without amyloidosis. Arch Neurol., 64, pp. 1388-1394.
23. Massignan, T., Casoni, F., Basso, M., Stefanazzi, P., Biasini, E. Tortarolo, M. et al. (2007) Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun., 353, pp. 719-725.
24. Arnaud, J. and Constans, J. (1993) Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet., 92, pp. 183-188.
25. Braun, A., Brandhofer, A. and Cleve, H. (1990) Interaction of the vitamin D-binding protein (group-specific component) and its ligand 25-hydroxy-vitamin D3: Binding differences of the various genetic types disclosed by isoelectric focusing. Electrophoresis., 11, pp. 478-483.
26. Verboven, C., Bogaerts, I., Waelkens, E., Rabijns, A., van Baelen, H. Bouillon, R. et al. (2003) Actin-DBP: The perfect structural fit?. Acta Crystallogr D Biol Crystallogr, 59, pp. 263-273.
27. Vasconcellos, CA and Lind, SE. (1993) Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein. Blood., 82, pp. 3648-3657.
28. Dahl, B., Schiodt, FV, Ott, P., Wians, F., Lee, WM Balko, J. et al. (2003) Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med., 31, pp. 152-156.
29. Lauridsen, AL, Vestergaard, P. and Nexo, E. (2001) Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem., 47, pp. 753-756.
30. Otterbein, LR, Cosio, C., Graceffa, P. and Dominguez, R. (2002) Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system. Proc Natl Acad Sci U S A., 99, pp. 8003-8008.
31. Shimizu, T., Hayashi, H., Kato, S., Hayashi, M., Tanabe, H. and Oda, M. (1994) Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J Neurol Sci., 124, pp. 45-55.
32. Elman, LB, Siderowf, A., Houseman, G., Kelley, M. and McCluskey, LF. (2005) Venous thrombosis in an ALS population over four years. Amyotroph Lateral Scler Other Motor Neuron Disord., 6, pp. 246-249.
33. Qureshi, MM, Cudkowicz, ME, Zhang, H. and Raynor, E. (2007) Increased incidence of deep venous thrombosis in ALS. Neurology., 68, pp. 76-77.
34. Greco, M., Chiriaco, F., Del Boccio, P, Tagliaferro, L., Acierno, R. Menegazzi, P. et al. (2006) A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. Proteomics, 6, pp. 5350-5361.
35. McGeer, PL and McGeer, EG. (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve., 26, pp. 459-470.
36. Henkel, JS, Engelhardt, JI, Siklos, L., Simpson, EP, Kim, SH Pan, T. et al. (2004) Presence of dendritic cells, MCP-1, and activated microglia/ macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol., 55, pp. 221-235.
37. Zhang, R., Gascon, R., Miller, RG, Gelinas, DF, Mass, J. Hadlock, K. et al. (2005) Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (SALS). J Neuroimmunol., 159, pp. 215-224.
38. Goldknopf, IL, Sheta, EA, Bryson, J., Folsom, B., Wilson, C. Duty, J. et al. (2006) Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem Biophys Res Commun., 342, pp. 1034-1039.